Document Type
Article
Language
eng
Publication Date
9-2013
Publisher
Elsevier
Source Publication
Virology
Source ISSN
0042-6822
Original Item ID
DOI: 10.1016/j.virol.2013.06.010
Abstract
The HIV-1 protein Vpr enhances macrophage infection, triggers G2 cell cycle arrest, and targets cells for NK-cell killing. Vpr acts through the CRL4DCAF1 ubiquitin ligase complex to cause G2 arrest and trigger expression of NK ligands. Corresponding ubiquitination targets have not been identified. UNG2 and SMUG1 are the only known substrates for Vpr-directed depletion through CRL4DCAF1. Here we identify the endoribonuclease Dicer as a target of HIV-1 Vpr-directed proteasomal degradation through CRL4DCAF1. We show that HIV-1 Vpr inhibits short hairpin RNA function as expected upon reduction of Dicer levels. Dicer inhibits HIV-1 replication in T cells. We demonstrate that Dicer also restricts HIV-1 replication in human monocyte-derived macrophages (MDM) and that reducing Dicer expression in MDMs enhances HIV-1 infection in a Vpr-dependent manner. Our results support a model in which Vpr complexes with human Dicer to boost its interaction with the CRL4DCAF1 ubiquitin ligase complex and its subsequent degradation.
Recommended Citation
Klockow, Laurieann; Sharifi, Hamayun J.; Wen, Xiaoyun; Flagg, Meg; Furuya, Andrea K.M.; Nekorchuk, Michael; and de Noronha, Carlos M.C., "The HIV-1 Protein Vpr Targets the Endoribonuclease Dicer for Proteasomal Degradation to Boost Macrophage Infection" (2013). Biomedical Sciences Faculty Research and Publications. 32.
https://epublications.marquette.edu/biomedsci_fac/32
Comments
Accepted version. Virology, Vol. 444, No. 1-2 (September 2013): 191-202. DOI. © 2013 Elsevier. Used with permission.
NOTICE: this is the author’s version of a work that was accepted for publication in Virology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Virology, VOL 444, ISSUE 1-2, September 2013, DOI.